Evidence map›Paper›PMID 40245048›Full record

ArticlePloS one2025

Protocol to evaluate the effectiveness of the implementation of transdiagnostic cognitive behavioural therapy for emotional disorders in primary care and its mechanisms of change: a randomized step-wedge clinical trial (PsicAP-CV).

Roger Muñoz-Navarro, Virtudes Pérez-Jover, Gabriel Esteller-Collado, Carlos Van-der Hofstadt Román, Monika Salgueiro, Anna Llorca-Mestre, Elisabeth Malonda-Vidal, Vera Canet-Cortell, M José Moraga-García, Ainhoa Coloma-Carmona and 13 more

Abstract readClinical Trial Protocol
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Roger Muñoz-NavarroDepartamento de Personalidad, Evaluación y Tratamientos Psicológicos, Facultad de Psicología, Universidad de Valencia, Valencia, España.ORCID 0000-0002-7064-3699
Virtudes Pérez-JoverDepartamento de Psicología de la Salud, Universidad Miguel Hernández, Elche, España.
Gabriel Esteller-ColladoDepartamento de Personalidad, Evaluación y Tratamientos Psicológicos, Facultad de Psicología, Universidad de Valencia, Valencia, España.ORCID 0000-0003-4110-2356
Carlos Van-der Hofstadt RománDepartamento de Psicología de la Salud, Universidad Miguel Hernández, Elche, España.
Monika SalgueiroDepartamento de Psicología Clínica y de la Salud y Metodología de Investigación. Facultad de Psicología, Universidad del País Vasco UPV/EHU, Donostia-San Sebastián, España.ORCID 0000-0002-2150-1221
Anna Llorca-MestreDepartamento de Psicología Básica. Facultad de Psicología, Universidad de Valencia, Valencia, España.
Elisabeth Malonda-VidalDepartamento de Psicología Básica. Facultad de Psicología, Universidad de Valencia, Valencia, España.ORCID 0000-0003-1970-924X
Vera Canet-CortellDepartamento de Personalidad, Evaluación y Tratamientos Psicológicos, Facultad de Psicología, Universidad de Valencia, Valencia, España.
M José Moraga-GarcíaInstituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
Ainhoa Coloma-CarmonaDepartamento de Psicología de la Salud, Universidad Miguel Hernández, Elche, España.ORCID 0000-0002-0857-9104
María Carpallo-GonzálezDepartamento de Personalidad, Evaluación y Tratamientos Psicológicos, Facultad de Psicología, Universidad de Valencia, Valencia, España.ORCID 0000-0002-7920-3171
Maider Prieto-VilaFacultad de Psicología, Universidad Complutense de Madrid, Madrid, España.ORCID 0009-0006-9115-2684
Sara Barrio-MartínezFacultad de Psicología, Universidad Complutense de Madrid, Madrid, España.
Ángel Aguilera-MartínDepartamento de Psicología, Universidad de Córdoba (España), Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía, Córdoba, Spain.
Mario Gálvez-LaraDepartamento de Psicología, Universidad de Córdoba (España), Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía, Córdoba, Spain.
Francisco Jurado-GonzálezDepartamento de Psicología, Universidad de Córdoba (España), Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía, Córdoba, Spain.
Elisa AguirreRedbridge Talking Therapies Service-North East London NHS Foundation Trust, London, United Kingdom.
César González-BlanchCentro de Salud Mental, Hospital Universitario Marqués de Valdecilla-IDIVAL, Santander, España.
Paloma Ruíz-RodríguezSector Embarcaciones, Centro de Atención Primaria, Servicio Madrileño de Salud, Tres Cantos, Madrid, España.ORCID 0000-0001-8140-0767
Juan Antonio MorianaDepartamento de Psicología, Universidad de Córdoba (España), Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía, Córdoba, Spain.ORCID 0000-0003-0577-821X
Paula Samper-GarcíaDepartamento de Psicología Básica. Facultad de Psicología, Universidad de Valencia, Valencia, España.ORCID 0000-0003-3788-7779
María Vicenta Mestre-EscriváDepartamento de Psicología Básica. Facultad de Psicología, Universidad de Valencia, Valencia, España.
Antonio Cano-VindelFacultad de Psicología, Universidad Complutense de Madrid, Madrid, España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEmotional disorders (ED) are highly prevalent worldwide. The PsicAP trial, conducted in Spain, demonstrated the benefits of adding transdiagnostic cognitive behavioural therapy (TD-CBT) to treatment as usual (TAU) for the attention of these disorders in primary care (PC). Here we describe the design of a stepped wedge randomized controlled trial (RCT), inspired by the PsicAP project. This RCT has two main aims: 1) to test the implementation of the PsicAP protocol in a real clinical setting, further evaluating possible mechanisms of change underlying the efficacy of TD-CBT (emotional regulation, alliance, and therapist experience and training), and 2) to assess the impact of psychotropic medication use on neuropsychological function and treatment outcomes.

methodsA single-blind multicentre RCT with a stepped wedge design will be conducted. Participants (N=320) will be randomly assigned to an experimental group (EG1) or to a waiting list group (WG). The EG1 will receive immediate treatment and the WG will remain on the waiting list for 3 months. After this time, the WG will become a second experimental group (EG2) that will receive the same treatment as EG1 (PsicAP protocol). Patients will be assessed at post-treatment, at 3 and 9 months. Before starting treatment, a random subsample of patients (n=90) will undergo a neuropsychological assessment. These patients will be assigned to three groups based on their use of psychotropic medication at the time of randomization: no psychotropic medication, short-term use (< 3 months) and long-term use (≥ 3 months). All 90 participants will undergo the same neuropsychological assessment at one year. The RCT is expected to run from 01/05/23 to 01/10/25. DISCUSSION: The results of this trial are expected to provide further support for the efficacy of the PsicAP TD-CBT protocol, as well as insight into the mechanisms of change that lead to the positive therapeutic outcomes of this protocol. In addition, this study will help determine the effects of short- and long-term psychotropic use on neuropsychological function and therapeutic outcomes. In short, it is hoped that this RCT will help to better understand how to implement evidence-based psychological treatment in the PC setting.

trial registrationEURADICT 2013-001955-11/ ISRCTN58437086.

Indexed as

Cognitive Behavioral TherapyAdultFemaleHumansMaleMiddle AgedMulticenter Studies as TopicPrimary Health CarePsychotropic DrugsRandomized Controlled Trials as TopicSingle-Blind MethodSpainTreatment OutcomePsychotropic Drugs

Identifiers

PMID40245048
PMCPMC12061397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.